Marco Di Antonio

Dr. Marco Di Antonio

1. Department of Chemistry, MSRH, Imperial College London, London SW12 0BX, UK
+1
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2015 in Nature Biotechnology
Verified
Journal Article
Closed access
VCVicki S Chambers
Vicki S Chambers
GMGiovanni Marsico
Giovanni Marsico
JBJonathan M Boutell
Jonathan M Boutell
MAMarco Di Antonio
Marco Di Antonio
GSGeoffrey P Smith
Geoffrey P Smith
SBShankar Balasubramanian
Shankar Balasubramanian

12 September 2016 in Nature Genetics
Verified
Journal Article
Closed access
RHRobert Hänsel-Hertsch
Robert Hänsel-Hertsch
DBDario Beraldi
Dario Beraldi
SLStefanie V Lensing
Stefanie V Lensing
GMGiovanni Marsico
Giovanni Marsico
KZKatherine Zyner
Katherine Zyner
SBShankar Balasubramanian
Shankar Balasubramanian

22 February 2017 in Nature Reviews Molecular Cell Biology
Verified
Journal Article
Closed access
RHRobert Hänsel-Hertsch
Robert Hänsel-Hertsch
MAMarco Di Antonio
Marco Di Antonio
SBShankar Balasubramanian
Shankar Balasubramanian

24 November 2013 in Nature Chemistry
Verified
Journal Article
Closed access
PDF file
GBGiulia Biffi
Giulia Biffi
MAMarco Di Antonio
Marco Di Antonio
DTDavid Tannahill
David Tannahill
SBShankar Balasubramanian
Shankar Balasubramanian

17 February 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
HXHong Xu
Hong Xu
MAMarco Di Antonio
Marco Di Antonio
SMSteven McKinney
Steven McKinney
VMVeena Mathew
Veena Mathew
BHBrandon Ho
Brandon Ho
SASamuel Aparicio
Samuel Aparicio
G-quadruplex DNAs form four-stranded helical structures and are proposed to play key roles in different cellular processes. Targeting G-quadruplex DNAs for cancer treatment is a very promising prospect. Here, we show that CX-5461 is a G-quadruplex stabilizer, with specific toxicity against BRCA deficiencies in cancer cells and polyclonal patient-derived xenograft models, including tumours resistant to PARP inhibition. Exposure to CX-5461, and its related drug CX-3543, blocks replication forks and induces ssDNA gaps or breaks. The BRCA and NHEJ pathways are required for the repair of CX-5461 and CX-3543-induced DNA damage and failure to do so leads to lethality. These data strengthen the concept of G4 targeting as a therapeutic approach, specifically for targeting HR and NHEJ deficient cancers and other tumours deficient for DNA damage repair. CX-5461 is now in advanced phase I clinical trial for patients with BRCA1/2 deficient tumours (Canadian trial, NCT02719977, opened May 2016).

20 March 2019 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
GMGiovanni Marsico
Giovanni Marsico
VCVicki S Chambers
Vicki S Chambers
ASAleksandr B Sahakyan
Aleksandr B Sahakyan
PMPatrick McCauley
Patrick McCauley
JBJonathan M Boutell
Jonathan M Boutell
SBShankar Balasubramanian
Shankar Balasubramanian
Genomic maps of DNA G-quadruplexes (G4s) can help elucidate the roles that these secondary structures play in various organisms. Herein, we employ an improved version of a G-quadruplex sequencing method (G4-seq) to generate whole genome G4 maps for 12 species that include widely studied model organisms and also pathogens of clinical relevance. We identify G4 structures that form under physiological K+ conditions and also G4s that are stabilized by the G4-targeting small molecule pyridostatin (PDS). We discuss the various structural features of the experimentally observed G-quadruplexes (OQs), highlighting differences in their prevalence and enrichment across species. Our study describes diversity in sequence composition and genomic location for the OQs in the different species and reveals that the enrichment of OQs in gene promoters is particular to mammals such as mouse and human, among the species studied. The multi-species maps have been made publicly available as a resource to the research community. The maps can serve as blueprints for biological experiments in those model organisms, where G4 structures may play a role.